Cardiology
News
Antipsychotic tied to dose-related weight gain, higher cholesterol
Risperidone is an antipsychotic with a “medium to high metabolic risk profile.”
News
ADA prioritizes heart failure in patients with diabetes
Patients with diabetes should have annual screening for biomarkers of early-stage heart failure, and treatment should prioritize an SGLT2...
News
Very high HDL-C: Too much of a good thing?
“Very high HDL levels are associated with increased risk of adverse outcomes, not lower risk, as previously thought.”
News
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Real-world study finds heart failure hospitalization reduction, compared with metformin but not MI, stroke, or overall mortality and with greater...
News
Takotsubo syndrome more deadly in men
Takotsubo syndrome, characterized by acute heart failure and transient ventricular contractile dysfunction, is more common in women but men are...
News
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
Several “standard care” therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
Latest News
Hormones account for 10% of lipid changes after menopause
“Menopause is not avoidable, but perhaps the negative metabolite shift can be diminished by lifestyle choices.”
News
Keeping thyroid hormone treatment on target is key for the heart
‘Both undertreatment and overtreatment were associated with adverse cardiovascular outcomes,’ including higher mortality, but keeping thyroid...
News
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
In the absence of additional risk factors, there was no indication of an elevated risk for AKI when an ACE inhibitor and NSAID are combined.
Conference Coverage
Exenatide linked to less hyperglycemia after stroke
The diabetes drug may offer better control than insulin for hyperglycemia, a common condition following stroke that leads to worse outcomes.